Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE)

NCT05703269 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05703269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Radiotherapy vs Single Fraction Radiosurgery for Brain Metastasis Patients on Immunotherapy (HYPOGRYPHE)
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 11, 2023
Completion date
March 31, 2028
Enrollment
58 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult, breast carcinoma, melanoma, non-small cell lung cancer, nsclc, renal cell carcinoma, sclc, small-cell lung cancer